Skip to main content

Advertisement

SpringerLink
Log in

Thalidomide combined with chemotherapy in treating elderly patients with advanced gastric cancer

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Aim

The current systemic chemotherapy brings toxicity to human body, which elder patients suffer more than young people. The effective and well-tolerated treatment methods are of great importance for elderly advanced GC patients. This paper proposed an effective way of combining thalidomide with chemotherapy to treat elderly advanced GC patients, on the purpose of improving life quality and the treatment efficacy.

Methods

In the control group, capecitabine was given with 2000 mg/m2 daily in a manner of 2 weeks on and 1 week off for elderly advanced GC patients. In the study group, thalidomide was given with 100 mg per day concurrently with chemotherapy additionally administered.

Results

No significant differences were observed in the major prognostic factors among 64 eligible patients between the study and control groups. The ORRs and DCRs of the treatment and control groups showed no significant difference (P > 0.05). PFS of the study and control groups were 5.3 months (95% CI 4.5–6.2) and 4.2 months (95% CI 3.4–5.1), respectively. PFS exhibited a significant difference between the two group (P = 0.03), while the overall survivals of the patients between the two groups (10.4 months vs. 9.7 months) resulted as statistically non-significant (P = 0.47). Adverse effects were minimal in the study group, only a few patients suffered the grade 3 toxicity. The rate of drowsiness, fatigue, constipation of the study group was higher than that of the control group, and the rate of anorexia was lower (P < 0.05).

Conclusions

Our results demonstrated that thalidomide combined with capecitabine was mildly effective and safe for treating elderly patients with advanced GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  2. Kim HS, Kim JH, Kim JW et al (2016) Chemotherapy in elderly patients with gastric cancer. J Cancer 7:88–94. doi:10.7150/jca.13248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chang SH, Kim SN, Choi HJ et al (2017) Adjuvant chemotherapy for advanced gastric cancer in elderly and non-elderly patients: meta-analysis of randomized controlled trials. Cancer Res Treat 49:263–273

    Article  PubMed  Google Scholar 

  4. Neugut Al, Matasar M, Wang XD et al (2006) Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 24:2368–2375

    Article  CAS  PubMed  Google Scholar 

  5. Sun DS, Jeon EK, Won HS et al (2015) Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy forrecurrent or metastatic gastric cancer. Gastric Cancer 18:644–652

    Article  CAS  PubMed  Google Scholar 

  6. Hwang JE, Kim HN, Kim DE et al (2012) First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status. Exp Ther Med 4:562–568

    Article  PubMed  PubMed Central  Google Scholar 

  7. Rajkumar SV, Witzig TE (2000) A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma. Cancer Treat Rev 26:351–362

    Article  CAS  PubMed  Google Scholar 

  8. Fine HA, Wen PY, Maher EA et al (2003) Phase II trial of thalidomide and carmustine for patients with recurrent highgrade gliomas. J Clin Oncol 21:2299–2304

    Article  CAS  PubMed  Google Scholar 

  9. Lago LD, Richter MF, Cancela AI et al (2003) Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer. Invest New Drugs 21:359–366

    Article  Google Scholar 

  10. Song L, Zhou X, Li X (2015) Phase II trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer. Mol. Clin Oncol 3:865–868

    CAS  Google Scholar 

  11. Gordon JN, Trebble TM, Ellis RD et al (2005) Thalidomide in the treatment of cancer cachexia: a randomised plcebo controlled trial. Gut 54:540–545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhou S, Kestell P, Tingle MD et al (2002) Thalidomide in cancer treatment: a potential in the elderly? Drugs Aging 19:85–100

    Article  CAS  PubMed  Google Scholar 

  13. Vasvari GP, Dyckhoff G, Kashfi F et al (2007) Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. Int J Cancer 121:1697–1704

    Article  CAS  PubMed  Google Scholar 

  14. Huang XE, Yan XC, Wang L et al (2015) Thalidomide Combined with Chemotherapy in Treating Patients with Advanced Colorectal Cancer, Asian Pac. J Cancer 17:7867–7869

    Google Scholar 

  15. Li L, Huan XE (2016) Thalidomide combined with chemotherapy in treating patients with advanced lung cancer. Asian Pac J Cancer Prev 17:2583–2585

    PubMed  Google Scholar 

  16. Shi SB, Wang M, Niu ZX et al (2012) Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer. Pancreatology 6:475–479

    Article  Google Scholar 

  17. Glimelius B, Ekstrom K, Hoffman K et al (1997) Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8:163–168

    Article  CAS  PubMed  Google Scholar 

  18. Pyrhonen S, Kuitunen T, Nyandoto P et al (1995) Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587–591

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Murad AM, Santiago FF, Petroianu A et al (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72:37–41

    Article  CAS  PubMed  Google Scholar 

  20. Zhang Y, Ma B, Huang XT et al (2016) Doublet versus single agent as second-line treatment for advanced gastric cancer: a meta-analysis of 10 randomized controlled trials. Medicine (Baltimore) 95:e2792

    Article  CAS  Google Scholar 

  21. Ohtsu A, Shah MA, Van Cutsem E et al (2011) Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 29:3968–3976

    Article  CAS  PubMed  Google Scholar 

  22. Franks ME, Macpherson GR, Figg WD (2004) Thalidomide. Lancet 363:1802–1811

    Article  CAS  PubMed  Google Scholar 

  23. D’Amato RJ, Loughnan MS, Flynn E et al (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082–4085

    Article  PubMed  PubMed Central  Google Scholar 

  24. Teo SK, Stirling DI, Zeldis JB et al (2005) DDT 10:107–114

    Article  CAS  PubMed  Google Scholar 

  25. Dredgea K, Dalgleisha AG, Marriotta JB et al (2003) Anticancer Drugs 14:331–335

    Article  Google Scholar 

  26. Olson KB, Hall TC, Horton J et al (1965) Thalidomide (N-phthaloylglutamimide > in the treatment of advanced cancer. Clin Pharmacol Ther 6:292–297

    Article  CAS  PubMed  Google Scholar 

  27. Gordinier ME, Dizon DS, Weitzen S et al (2000) Oral thalidomide as palliative chemotherapy in woman with advanced ovarian cancer. J Palliat Med 10:61–66

    Article  Google Scholar 

  28. Sullivan D, Faccio R, Levy ML et al (2003) The assassination of President John F Kennedy: a neuroforensic analysis-part 1: a neurosurgeon’s previously undocumented eyewitness account of the events of November 22, 1963. Neurosurgery 53:1019–1025 (discussion 1025–1027)

    Article  PubMed  Google Scholar 

  29. Kripke DF, Garfinkel L, Wingard DL et al (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136

    Article  PubMed  Google Scholar 

  30. Irwin MR (2013) Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep 15:404

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China

      Ya Li, Yanjun Chu, Ruifeng Song & Feng Xu

    Authors
    1. Ya Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Yanjun Chu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Ruifeng Song
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Feng Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Feng Xu.

    Ethics declarations

    Conflict of interest

    No potential conflicts of interest are disclosed.

    Ethical approval

    The trial was approved by the Regional Ethical Review Board.

    Informed consent

    All patients were provided an informed written consent before study entry.

    Additional information

    Ya Li and Yanjun Chu contributed equally to this study.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Li, Y., Chu, Y., Song, R. et al. Thalidomide combined with chemotherapy in treating elderly patients with advanced gastric cancer. Aging Clin Exp Res 30, 499–505 (2018). https://doi.org/10.1007/s40520-017-0790-z

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40520-017-0790-z

    Keywords

    Search

    Navigation